Young Investigators’ Meeting 2016

We are excited to announce that we will be holding a Young Investigators’ Meeting (YIM) on the occasion of the International Workshop of the German CLL Study Group.

The YIM provides the opportunity for aspiring clinical, translational and basic scientists to share and discuss their research on an international level. Senior CLL scientists are also encouraged to join the meeting and provide their own views and experiences to the discussions. By this, the YIM has become a major platform for young CLL researchers to present innovative research, receive feedback and foster new collaborations.

We invite you to submit an abstract related to basic or clinical research from the wide area of CLL. Depending on the number and quality of submitted abstracts, authors will get the chance to present their data as oral presentations and/or posters. Outstanding contributions will be presented in the main program as well.

Travel funding

Authors of accepted oral abstracts will receive travel grants to assist with travel expenses. Applicants should be 40 years or younger.

Abstract submission

Please consider submitting your abstract until the 27th June 2016 by sending a word document with a max. word count of 500 words to

Friday, September 16th 2016

12.00 - 1.00 pm

Lunch

1.00 - 1.15 pm

Microenvironmental stromal cells trigger hypoxia signalling in cll cells - a mechanism that provides protection from apoptosis and can be targeted therapeutically

Deyan Yosifov, Ulm (GE)

1.15 - 1.30 pm

Ebv-specific cd8+ t-cells are functionally impaired in chronic lymphocytic leukemia

Tom Hofland, Amsterdam (NL)

1.30 - 1.45 pm

Genomic markers of drug sensitivity in primary blood cancer cells

Sascha Dietrich, Heidelberg (GE)

1.45 - 2.00 pm

Targeting endoplasmic reticulum-resident proteins for the treatment of chronic lymphocytic leukemia

Chih-Hang Anthony Tang, Tampa (USA)

2.00 - 2.15 pm

The kinase inhibitors r406 and gs-9973 impair t cell functions in chronic lymphocytic leukemia (cll) patients

Mercedes Borge, Buenos Aires (AR)

2.15 - 2.30 pm

Non-coding notch1 mutations in chronic lymphocytic leukaemia; their clinical impact in the lrf uk cll4 clinical trial

Stuart J. Blakemore, Southampton (UK)

2.30 - 2.45 pm

Akt activation in chronic lymphocytic leukemia cells promotes transformation towards aggressive richter’s syndrome lymphoma

Nadine Nickel, Cologne (GE)

2.45 - 3.00 pm

Loss of toso promotes richter´s transformation of tcl1a driven cll

Lukas Frenzel, Cologne (GE)

3.00 - 3.30 pm

Pitfalls and opportunities – pursuing a career in cll research

Tbd

We look very much forward to meeting you in Cologne! 

Kind regards,

Jennifer Woyach, MD, Columbus
Matthew Davids, MD, Boston
Shih-Shih Chen, PhD, New York
Giles Best, PhD, Sydney
Jacqueline Barrientos, MD, New York
Othman Al-Sawaf, MD, Cologne
Kirsten Fischer, MD, Cologne